#	Pagina
attuale pagina	/open-h2020/projects/225677/index.html

Opendata, web and dolomites

BacterOMIC SIGNED

Intelligence for precision therapies against antimicrobial resistance: The first diagnostic panel that probes all the clinically relevant antibiotics at once

Total Cost €

EC-Contrib. €

Partnership

Views

BacterOMIC project word cloud

Explore the words cloud of the BacterOMIC project. It provides you a very rough idea of what is the project "BacterOMIC" about.

private tests ast rapid companies optimize es biotechnology era mass billion effect consuming trials elevates pathogens business commercialization drugs treatment biggest antibiotics market certify eur first laboratories validate that ch fr clear health 1 de clinical few certain disease ready 2018 lists combinations valued threats optimal cumulative bacteria threat resistance profit hospitals antimicrobial successful model diagnostic prepare pt pharmaceutical contract instrument single million bacteromic network manual susceptibility centers drastic antibiotic global resistant bacterial sme laborious 2022 time inappropriate changed patients pl microorganisms days unlike cagr multiple 4h automatic healthcare turns constantly infection 2025 treating

Project "BacterOMIC" data sheet

The following table provides information about the project.

Coordinator	BACTEROMIC SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA Organization address address: UL. DUCHNICKA 3 BUD 16 LOK WEJSCIE A city: WARSAW postcode: 01 796 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Poland [PL]
Total cost	2˙752˙387 €
EC max contribution	1˙926˙671 € (70%)
Programme	1. H2020-EU.3. (PRIORITY 'Societal challenges) 2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs) 3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
Code Call	H2020-SMEInst-2018-2020-2
Funding Scheme	SME-2
Starting year	2019
Duration (year-month-day)	from 2019-08-01 to 2021-07-31

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	BACTEROMIC SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA BACTEROMIC SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA Organization address address: UL. DUCHNICKA 3 BUD 16 LOK WEJSCIE A city: WARSAW postcode: 01 796 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	PL (WARSAW)	coordinator	1˙926˙671.00

Map

Project objective

In the recent years, we have seen a drastic increase in the antibiotic resistance among bacterial pathogens. This is considered as one of the biggest threats to global health in the current era. The reason for that is inappropriate use of antibiotics - patients are often treated with not optimal antibiotic that need to be changed after few days. Number of resistant microorganisms constantly elevates due to inappropriate use of antibiotics - patients are often treated with inappropriate drugs that need to be changed after few days if bacteria turns to be resistant. The reason for that is that current manual antibiotic resistance tests are time-consuming and laborious, while automatic antimicrobial tests offer analysis of a short lists of antibiotics. BacterOMIC is a response to the growing global threat of antibiotic resistance. We provide the first fully comprehensive rapid Antimicrobial Susceptibility Testing (AST) system to determine already in 4h which from all common antibiotics will be most successful in treating certain bacterial infection. Unlike current methods, our system also allows to investigate antimicrobial effect of not only single antibiotics but also combinations of multiple antibiotics – the future of infection disease treatment. Constantly growing antimicrobial susceptibility testing market was valued at EUR 2.4 billion in 2018 and is expected to reach EUR 3.1 billion by 2022 at the CAGR of 5.1%. With our clear business model we target pharmaceutical and biotechnology companies, contract research organizations, hospitals/private healthcare centers, and diagnostic laboratories. We have a network of partnerships across the EU (PL, FR, ES, CH, DE, and PT) and we are ready for rapid scale-up, with more than 30 million cumulative profit by 2025. We need SME Instrument phase 2 to optimize the design, prepare for mass production, validate the system in clinical trials, and certify it for successful commercialization.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BACTEROMIC" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BACTEROMIC" are provided by the European Opendata Portal: CORDIS opendata.